Alina Venezia
Director of Investor Relations
Replay available
Esperion Therapeutics, Inc. (NASDAQ: ESPR) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Director of Investor Relations
President & CEO
CFO
Analyst, Jefferies
Analyst, Bank of America
Analyst, Cantor Fitzgerald
Analyst, JP Morgan
Watch the replay and follow the connected company analysis, news, and investor updates for Esperion Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:03.515 Ladies and gentlemen, thank you for standing by and welcome. 00:00:03.515 -- 00:00:06.879 At this time, all participants are in listen-only mode. 00:00:06.879 -- 00:00:10.323 Following the presentation, it will be a question-and-answer session. 00:00:10.323 -- 00:00:13.888 Please be advised that today's conference call will be recorded. 00:00:13.888 -- 00:00:19.374 I would now like to hand the conference over to Alina Venezia, Director of Investor Relations 00:00:19.374 -- 00:00:22.758 for Experion Therapeutics. Please go ahead. 00:00:22.758 -- 00:00:28.625 Thank you, Operator. Good morning, and welcome to Experion's first quarter 2025 earnings 00:00:28.625 -- 00:00:34.376 conference call. With us on today's call are Sheldon Koenig, President and CEO, 00:00:34.376 -- 00:00:36.800 and Ben Halliday, CFO. 00:00:36.800 -- 00:00:41.686 Other members of the executive team will be available for Q&A following our prepared 00:00:41.686 -- 00:00:43.686 remarks. 00:00:44.110 -- 00:00:48.796 We issued a press release earlier this morning detailing the content of today's call. 00:00:48.796 -- 00:00:53.503 A copy can be found on the investor page of our website, together with a copy of the 00:00:53.503 -- 00:00:56.225 presentation that we will also be referencing. 00:00:56.225 -- 00:01:00.369 I want to remind callers that the information discussed on the call today is covered 00:01:00.369 -- 00:01:05.635 under the safe harbor provisions of the Private Securities Litigation Reform Act. 00:01:05.635 -- 00:01:09.819 I caution listeners that management will be making forward-looking statements. 00:01:09.819 -- 00:01:14.624 Actual results could differ materially from those stated or implied by our forward-looking 00:01:14.624 -- 00:01:19.469 statemen...